Moreover, in the present study, the 5-HT4R agonists prucalopride and velusetrag restored the decrease in cAMP levels and the reduced number of p-CREB-positive cells in the hippocampal DG of PD mice (Figure 5 and Figure 6). This evidence concerns the gene HTR4 and Parkinson disease.